Reid Hoffman Bets on A.I. Drug Discovery with a Pulitzer-Winning Cancer Physician
Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is expected to generate between $60 billion and $110 billion annually in value for the pharmaceutical and medical-product industries, according to a McKinsey report released last year.
1don MSN
Reid Hoffman, Greylock partner, Inflection AI and LinkedIn co-founder, and ‘Superagency' author, joins 'Squawk Box' to ...
The LinkedIn founder talks about his new book, ‘Superagency,’ and argues that people can use AI to reshape their daily work lives.
What Could Possibly Go Right with Our AI Future," the LinkedIn co-founder makes the case that AI can extend human ...
3don MSN
LinkedIn founder Reid Hoffman has been immersed in Silicon Valley since his August 1967 birth in Palo Alto, California, in ...
Hosted on MSN1d
🎧 How to Prepare for AGI According to Reid HoffmanToday we’re releasing a new episode of our podcast AI & I. I go in depth with Reid Hoffman, cofounder of LinkedIn, author, ...
Manas AI Inc., a startup using artificial intelligence to discover new medicines, launched today with $24.6 million in ...
LinkedIn co-founder and AI investor Reid Hoffman argues we shouldn't be afraid of AI or its disruptive capabilities in his ...
Dedicated to spotlighting global leaders, the Tarnopol series serves as a platform for addressing critical societal issues, ...
Human agency is the notion that as an individual you have the capacity to make your own choices, act independently and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback